Mayo Clinic Polycystic Kidney Disease Resource Center for PKD research
Official title: Mayo Clinic Polycystic Kidney Disease Research Core Center
Funded at Mayo Clinic Rochester · NIH-11418445 · Data updated 2026-11-12
A Mayo Clinic center provides researchers with PKD samples, data, and tools to help advance understanding and treatment of polycystic kidney disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 22, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $260,668 |
| NIH project number | 5U54DK144863-02 |
| Project ID | NIH-11418445 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to patient participation; this is a resource center supporting PKD researchers and their studies.
✕Less likely to help
Direct patient participation is not required for this grant since it funds infrastructure and data resources.
What this research studies
The Mayo Clinic Polycystic Kidney Disease Research Core Center offers access to a rich PKD resource network, including patient DNA, biobanked samples, imaging data, and developed software, to support PKD research. Researchers can collaborate through the PKD-Research Resource Consortium to obtain reagents, data, and technical support. The center emphasizes deep, longitudinal phenotyping of ADPKD patients to enable new discoveries and potential therapies. This grant funds the Core Center’s operations, data sharing, and training activities to accelerate PKD science.
Why it matters
Potential benefit: Improved understanding and accelerated development of therapies for PKD based on rich patient data and research resources.
How similar studies have gone: PKD resource centers have previously accelerated PKD discoveries by enabling data sharing and multi-center collaborations.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: Harris, Peter C. — Mayo Clinic Rochester
- Study coordinator: Harris, Peter C.
Related research
Other NIH-funded projects on the same topics.
-
Personalized CKD-MBD care using systems biology and AI
A patient-facing program aims to tailor mineral-balance therapy for people with chronic kidney disease by using a computer model and smart decision rules to predict who will respond best to treatments.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Chronic Kidney Disease in Children: following young people as they grow up with CKD
A long-term study in kids with chronic kidney disease tracks kidney function and heart health as they transition into adulthood.
-
Chronic Kidney Disease in Children follow-up study
A long-term study that follows kids with kidney disease as they grow into young adults, collecting health data from home and official records.
-
KDARC: Building a research backbone to study aging and kidney disease
Aimed at creating a dedicated infrastructure to advance aging-related kidney disease research so clinicians can better care for older adults.
-
Malaria-related kidney injury and its link to chronic kidney disease in children
This grant looks at why some children who have malaria develop kidney injury and later chronic kidney disease, focusing on how severe malaria affects the kidneys over time.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.